SB Exits "Ix": Informatics Legacy Embodied By R&D Head Yamada
Executive Summary
SmithKline Beecham may retain the legacy of its experiment in building an "informatics" business through the appointment of Tadataka Yamada, MD, as its new head of research and development.
You may also be interested in...
Roche Vision Of Rx Future Includes IT And China, But Not Large Sales Force
Roche is keeping a close watch on information technology companies as potential emerging competitors for the pharmaceutical industry, CFO Erich Hunziker told the recent J.P. Morgan health care conference in San Francisco
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011